semaglutide causing depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 Agonists Can Affect Mood:

Similar to all medications, Semaglutide can often bring some mild side effects

Diabetes itself increases NAION risk, creating particularly dangerous situations when patients take GLP-1 medications that multiply already elevated baseline risk

These were usually mild to moderate and improved over time

We have many referrals for these medications, specifically for weight loss and for other reasons

Quality control measures are implemented throughout the compounding process to verify the accuracy of ingredient measurements, sterility of the final product, and absence of particulate matter or other contaminants

Subsequent check-ins occur every 46 weeks, allowing us to fine-tune the regimen and monitor progress